Researcher.Life Logo

Cancer Immunology Research : Impact Factor & More

eISSN: 2326-6074pISSN: 2326-6066

Key Metrics

CiteScore
17.4
Eigenfactor
0.01 - 0.05
H-Index
116
Impact Factor
10 - 15
SJR
Q1Immunology
SNIP
1.86
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Immunology Research

Cancer Immunology Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher AMER ASSOC CANCER RESEARCH
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2013
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Cancer Immunology Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Immunology Research

Multinucleated giant cells in human pancreatic cancer are a distinct macrophage population undergoing a DNA damage response and associated with an aggressive tumor microenvironment.
  • 30 Jun 2026
  • Cancer immunology research
Fueling Immunotherapy Resistance: SSBP4 Links Tumor Cholesterol Biosynthesis to Immune Evasion.
  • 29 Jun 2026
  • Cancer immunology research
Cancer intrinsic protein neddylation modulates the intra-tumoral immune landscape to constrain immune checkpoint blockade therapy.
  • 22 Jun 2026
  • Cancer immunology research
ADAR1 deficiency in pancreatic cancer cells potentiates cDC1 activation and promotes sensitization to immunotherapy.
  • 17 Jun 2026
  • Cancer immunology research
DNA hypomethylating agents preserve T cell stemness and potentiate the efficacy of CD3-bispecific antibodies.
  • 11 Jun 2026
  • Cancer immunology research
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells.
  • 11 Jun 2026
  • Cancer immunology research
Multinucleated giant cells in human pancreatic cancer are a distinct macrophage population undergoing a DNA damage response and associated with an aggressive tumor microenvironment.
  • 30 Jun 2026
  • Cancer immunology research
Fueling Immunotherapy Resistance: SSBP4 Links Tumor Cholesterol Biosynthesis to Immune Evasion.
  • 29 Jun 2026
  • Cancer immunology research
Cancer intrinsic protein neddylation modulates the intra-tumoral immune landscape to constrain immune checkpoint blockade therapy.
  • 22 Jun 2026
  • Cancer immunology research
ADAR1 deficiency in pancreatic cancer cells potentiates cDC1 activation and promotes sensitization to immunotherapy.
  • 17 Jun 2026
  • Cancer immunology research
DNA hypomethylating agents preserve T cell stemness and potentiate the efficacy of CD3-bispecific antibodies.
  • 11 Jun 2026
  • Cancer immunology research
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells.
  • 11 Jun 2026
  • Cancer immunology research

FAQs on Cancer Immunology Research